Chronic myeloid leukaemia in Spain: Its presentation characteristics have changed. Spanish section of the EUTOS population-based registry
Santiago Osorio(Institut Català d'Oncologia), Juan Luis Steegmann(Hospital Universitario de La Princesa), M. Andrade(Hospital Universitario Miguel Servet), Pilar Giraldo(Université Paris-Saclay), Rosa Ayala(Hospital Universitario 12 De Octubre), Beatriz Maestro(Universitat de Miguel Hernández d'Elx), Luis Casado(Hospital Universitario de La Princesa), Valentín García‐Gutiérrez(Universidad de Alcalá), N. García(Hospital Virgen de la Salud), Sara Redondo(Hospital de Sant Pau)
Cited by 4
Related Papers
A New Prognostic Score for Survival of Patients With Chronic Myeloid Leukemia Treated With Interferon Alfa Writing Committee for the Collaborative CML Prognostic Factors Project Group
|JNCI Journal of the National Cancer Institute|1998|820
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia
|Leukemia|2016|473
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464